BIOY vs. NVD

Last updated Jun 30, 2026

BIOY (GraniteShares YieldBOOST Biotech ETF) and NVD (GraniteShares 2x Short NVDA Daily ETF) are both exchange-traded funds - BIOY is a Derivative Income fund actively managed by GraniteShares, while NVD is a Inverse Equities fund actively managed by GraniteShares. Both are actively managed. At a correlation of -0.28, they often move in opposite directions. BIOY charges 1.07%/yr vs 1.50%/yr for NVD.

Performance

BIOY vs. NVD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GraniteShares YieldBOOST Biotech ETF (BIOY) and GraniteShares 2x Short NVDA Daily ETF (NVD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BIOY

• 1D: 0.04%
• 1M: 0.80%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVD

• 1D: -3.17%
• 1M: 12.04%
• YTD: -23.22%
• 6M: -21.68%
• 1Y: -51.35%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BIOY vs. NVD - Yearly Performance Comparison

	2026 (YTD)
BIOY GraniteShares YieldBOOST Biotech ETF	0.69%
NVD GraniteShares 2x Short NVDA Daily ETF	-3.51%

Correlation

The correlation between BIOY and NVD is -0.28, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (All Time) Calculated using the full available price history since May 5, 2026	-0.28

Return for Risk

BIOY vs. NVD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

NVD

NVD Risk / Return Rank: 4
NVD Sharpe Ratio Rank: 4
NVD Sortino Ratio Rank: 4
NVD Omega Ratio Rank: 4
NVD Calmar Ratio Rank: 3
NVD Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIOY vs. NVD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GraniteShares YieldBOOST Biotech ETF (BIOY) and GraniteShares 2x Short NVDA Daily ETF (NVD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BIOY	NVD	Difference
Sharpe ratio: Return per unit of total volatility	—	-0.73	—
Sortino ratio: Return per unit of downside risk	—	-0.91	—
Omega ratio: Gain probability vs. loss probability	—	0.90	—
Calmar ratio: Return relative to maximum drawdown	—	-0.77	—
Martin ratio: Return relative to average drawdown	—	-1.26	—

Drawdowns

BIOY vs. NVD - Drawdown Comparison

The maximum BIOY drawdown since its inception was -5.07%, smaller than the maximum NVD drawdown of -99.26%. Use the drawdown chart below to compare losses from any high point for BIOY and NVD.

Drawdown Indicators

	BIOY	NVD	Difference
Max Drawdown Largest peak-to-trough decline	-5.07%	-99.26%	+94.19%
Max Drawdown (1Y) Largest decline over 1 year	—	-66.81%	—
Current Drawdown Current decline from peak	-0.76%	-98.97%	+98.21%
Average Drawdown Average peak-to-trough decline	-2.21%	-81.95%	+79.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	40.69%	—

Volatility

Volatility by Period

	BIOY	NVD	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	27.02%	—
Volatility (6M) Calculated over the trailing 6-month period	—	53.97%	—
Volatility (1Y) Calculated over the trailing 1-year period	16.02%	70.92%	-54.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.02%	92.41%	-76.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.02%	92.41%	-76.39%

BIOY vs. NVD - Expense Ratio Comparison

BIOY has a 1.07% expense ratio, which is lower than NVD's 1.50% expense ratio.

Dividends

BIOY vs. NVD - Dividend Comparison

BIOY's dividend yield for the trailing twelve months is around 9.48%, less than NVD's 15.40% yield.

Position	TTM	2025	2024	2023
BIOY GraniteShares YieldBOOST Biotech ETF	9.48%	0.00%	0.00%	0.00%
NVD GraniteShares 2x Short NVDA Daily ETF	15.40%	11.83%	8.68%	15.78%

Frequently Asked Questions

Can I hold both BIOY and NVD in my portfolio?

BIOY and NVD have a correlation of -0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, BIOY or NVD?

On fees, BIOY is cheaper at 1.07% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BIOY or NVD?

BIOY is cheaper with a 1.07% expense ratio, compared with 1.50% for NVD.

Which ETF pays a higher dividend yield, BIOY or NVD?

NVD has the higher dividend yield at 15.40%, compared with 9.48% for BIOY.

What is the main difference between BIOY and NVD?

BIOY is categorized as Derivative Income, while NVD is Inverse Equities. Their fees differ too: 1.07% for BIOY and 1.50% for NVD.